Saranya Proteins Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.00 Cr
as on 24-10-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.53 Cr
as on 24-10-2024
- Revenue 31.15%
(FY 2023)
- Profit 82.92%
(FY 2023)
- Ebitda 19.89%
(FY 2023)
- Net Worth -11.26%
(FY 2023)
- Total Assets 83.43%
(FY 2023)
About Saranya Proteins
The Corporate was formerly known as Saranya Protiens Limited. The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹4.53 Cr.
Parimala Mohan and Narayanapati Sowjanya serve as directors at the Company.
- CIN/LLPIN
U15499TN2002PTC048986
- Company No.
048986
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2002
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Saranya Proteins?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parimala Mohan  | Director | 01-Apr-2017 | Current |
| Narayanapati Sowjanya | Director | 01-Apr-2017 | Current |
Financial Performance of Saranya Proteins.
Saranya Proteins Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.15% increase. The company also saw a substantial improvement in profitability, with a 82.92% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saranya Proteins?
In 2023, Saranya Proteins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innovative Healthcare (India) Private LimitedActive 24 years 11 monthsNarayanapati Sowjanya is a mutual person
Nutri Flavours Private LimitedActive 20 years 10 monthsParimala Mohan and Narayanapati Sowjanya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Jul 2024 | ₹4.53 Cr | Open |
How Many Employees Work at Saranya Proteins?
Unlock and access historical data on people associated with Saranya Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saranya Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saranya Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
